Investing.com - UCB reported on Thursday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
UCB announced earnings per share of €2.52 on revenue of €1.43B. Analysts polled by Investing.com anticipated EPS of €2.68 on revenue of €2.26B.
UCB shares are up 6% from the beginning of the year, still down 14.43% from its 52 week high of €107.40 set on November 12, 2021. They are outperforming the STOXX 600 which is down 10.01% from the start of the year.
UCB follows other major Healthcare sector earnings this month
UCB's report follows an earnings matched by Oxurion on Tuesday, who reported EPS of €-0.17 on revenue of €165K, compared to forecasts EPS of €-0.17 on revenue of €0.17M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar